Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/45301
Título
Impact of the rotavirus vaccine in Valladolid, Spain: An interrupted time series analysis
Autor
Año del Documento
2016
Editorial
Elsevier
Descripción
Producción Científica
Documento Fuente
Trials in Vaccinology, 2016, vol. 5, p. 84-87
Zusammenfassung
Rotavirus vaccines (RV) have decreased the infant morbidity and mortality in countries that included RV
in their national schedule. Rotavirus vaccination is recommended by the Spanish Society of Pediatrics;
however, Spain, as most countries in Europe, has authorized commercialization but not included RV in
its national vaccination program. We assessed the impact of RV on the rotavirus hospitalization rate
through an interrupted time series analysis. There was a 46.8% (95% CI: 29.3–60.2) decrease on the rotavirus
hospitalizations rate in the study region after RV commercialization in 2006. Currently there is limited
evidence about the impact of RV in Europe, especially among countries not offering systematic
vaccination in their national schedule. Documentation of RV coverage, effectiveness and impact is
urgently needed in these countries.
Materias Unesco
32 Ciencias Médicas
Palabras Clave
Rotavirus
Vaccine
ISSN
1879-4378
Revisión por pares
SI
Version del Editor
Propietario de los Derechos
© 2016 Published by Elsevier Ltd.
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Dateien zu dieser Ressource
![Attribution-NonCommercial-NoDerivatives 4.0 Internacional](/themes/Mirage2//images/creativecommons/cc-by-nc-nd.png)